|
|
||||||||
ORIGINAL RESEARCH |
From the Department of Obstetrics and Gynecology, Gifu University School of Medicine, Gifu City, Japan; and Department of Obstetrics and Gynecology, Iwasa Hospital, Gifu City, Japan.
Address reprint requests to: Yuichiro Takahashi, MD, PhD, Gifu University School of Medicine, Department of Obstetrics and Gynecology, Tsukasamachi-40, Gifu City, 500-8705, Japan; E-mail: y-taka{at}cc.gifu-u.ac.jp.
| ABSTRACT |
|---|
|
|
|---|
METHODS: We measured the levels of umbilical arterial and venous leptin, umbilical cord gas, umbilical venous blood glucose, and estradiol-17ß (E2) in 89 pregnant women. Correlation between the leptin levels and other variables (gestational age, birth weight, maternal body weight, height, body mass index, maternal body weight gain, placental weight, umbilical cord gas data, and levels of umbilical venous blood glucose and E2) were examined statistically.
RESULTS: Umbilical arterial and venous leptin levels were 7.64 ± 12.76 and 7.76 ± 13.17 (ng/mL), respectively, correlating positively with carbon dioxide pressure levels (r = 0.446, P < .001; r = 0.406, P < .001, respectively) and correlating inversely with pH (r = -0.337, P =.001; r = -0.247, P = .019, respectively). Umbilical venous glucose, E2, and other factors did not correlate with leptin levels.
CONCLUSION: Leptin secretion into the fetoplacental circulation may be associated with fetal hypercapnia, suggesting two important roles for leptin: one for basal control of fetal fat tissue and one as an acute stress-related hormone.
Leptin is a 16-kD protein encoded by the ob gene. It is a hormone secreted by adipocytes1 and acts on the hypothalamic centers to regulate body weight,2 causing a decrease in food intake and an increase in body temperature and energy expenditure.3,4 In 1997, Masuzaki et al demonstrated leptin production in nonadipose tissues such as human placental trophoblastic and amniotic cells and in gestational trophoblastic neoplasms.5 The biological implication of circulated fetoplacental leptin is still controversial. Birth weight and placental weight positively correlated with umbilical cord blood leptin level,69 which has an independent association with intrauterine growth restriction10,11 and macrosomia.12 Maternal serum leptin was drastically reduced after placenta delivery,5 yet there was no correlation between maternal and cord leptin levels.13 This evidence shows that leptins fetoplacental circulation is independent of its maternal circulation. The release of leptin from placenta into the fetal circulation was very low, compared with the release into the maternal circulation.14 Fetoplacental circulation of leptin may be influenced not only by fetal growth and fat tissue, but also by other related systems.
In adult humans, leptin is discussed as a stress-related hormone.1518 Chronic or repeated stress results in reduction of food intake and body weight in rats,19 suggesting that leptin plays a bridging role between stress and body fat control for maintaining homeostasis and energy supply. The aim of the present study is to clarify a plausible relationship between fetal distress and leptin secretion in fetoplacental circulation. Our hypothesis was that leptin may be not only a growth-related hormone but also a bridging hormone between fetal stress and fetal energy control (fetal fat tissue decrease and fetal growth restriction).
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
The paired Student t test for analysis of UA and UV leptin level differences was performed, and multivariate analysis between leptin levels and other variablesgestational age, birth weight, maternal body weight, maternal body weight gain, maternal height, maternal body mass index, placental weight, UV blood glucose, UV E2, UA and UV pH, oxygen pressure, carbon dioxide pressure, and base excess (Tables 1
and 2
) was performed. A P value of <.05 was considered significant. We evaluated the fetal stress using the umbilical cord gas analysis after birth.
|
| RESULTS |
|---|
|
|
|---|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Leptin secretion is increased in a human trophoblastic carcinoma cell line (BeWo cells) under hypoxic conditions, compared with those under normal conditions.24 The experiment may indicate that additional leptin secretion in the fetoplacental circulation has some relation with fetal asphyxia, but the evidence supported by that report is at present insufficient.
Cord blood hypertriglyceridemia is important for fetal energy supply when the fetus becomes asphyxic.25 Fetal hypoxia induces hypersecretion of catecholamines from fetal adrenal glands and accelerates the energy production of blood glucose from glycogen. When a fetus undergoes stress, free fatty acid may be secreted as a second energy source to compensate for increased glucose consumption, and leptin may have some relation with this mechanism. These metabolic features may have some connection to fetoplacental leptin secretion.
In conclusion, although the pathophysiology of leptin secretion in the fetoplacental circulation is complicated and leptin secretion seemingly has contradictory functions, it seems likely that leptin may have two important roles: one as an acute stress-related hormone, and the other for fetal fat mass control. Further investigation into these theories could possibly clarify some mechanisms of fetal growth restriction and fetal asphyxia.
| Footnotes |
|---|
Received September 10, 2001. Received in revised form March 29, 2002. Accepted April 18, 2002.
| REFERENCES |
|---|
|
|
|---|
2. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:2925.
3. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:5403.
4. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269: 5436.
5. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, et al. Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans. Nat Med 1997;3:102933.[Medline]
6. Schubring C, Kiess W, Englaro P, Rascher W, Dotsch J, Hanitsch S, et al. Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: Relation to neonatal and placental weight. J Clin Endocrinol Metab 1997;82:14803.
7. Geary M, Pringle PJ, Persaud M, Wilshin J, Hindmarsh PC, Rodeck CH, et al. Leptin concentrations in maternal serum and cord blood: Relationship to maternal anthropometry and fetal growth. Br J Obstet Gynaecol 1999;106: 105460.[Medline]
8. Jaquet D, Leger J, Levy-Marchal C, Oury JF, Czernichow P. Ontogeny of leptin in human fetuses and newborns: Effect of intrauterine growth retardation on serum leptin concentrations. J Clin Endocrinol Metab 1998;83:12436.
9. Cetin I, Morpurgo PS, Radaelli T, Taricco E, Cortelazzi D, Bellotti M, et al. Fetal plasma leptin concentrations: Relationship with different intrauterine growth patterns from 19 weeks to term. Pediatr Res 2000;48:64651.[Medline]
10. Varvarigou A, Mantzoros CS, Beratis NG. Cord blood leptin concentrations in relation to intrauterine growth. Clin Endocrinol (Oxf) 1999;50:17783.[Medline]
11. Shekhawat PS, Garland JS, Shivpuri C, Mick GJ, Sasidharan P, Pelz CJ, et al. Neonatal cord blood leptin: Its relationship to birth weight, body mass index, maternal diabetes, and steroids. Pediatr Res 1998;43:33843.[Medline]
12. Wiznitzer A, Furman B, Zuili I, Shany S, Reece EA, Mazor M. Cord leptin level and fetal macrosomia. Obstet Gynecol 2000;96:70713.
13. Laml T, Hartmann BW, Ruecklinger E, Preyer O, Soeregi G, Wagenbichler P. Maternal serum leptin concentrations do not correlate with cord blood leptin concentrations in normal pregnancy. J Soc Gynecol Invest 2001;8:437.[Medline]
14. Linnemann K, Malek A, Sager R, Blum WF, Schneider H, Fusch C. Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab 2000;85:4298301.
15. Bornstein SR. Is leptin a stress related peptide? Nat Med 1997;3:937.[Medline]
16. Hernandez C, Simo R, Chacon P, Sabin P, Baena JA, Castellanos JM, et al. Influence of surgical stress and parenteral nutrition on serum leptin concentration. Clin Nutr 2000;19:614.[Medline]
17. Pickup JC, Chusney GD, Mattock MB. The innate immune response and type 2 diabetes: Evidence that leptin is associated with a stress-related (acute-phase) reaction. Clin Endocrinol 2000;52:10712.[Medline]
18. Wallace AM, Sattar N, McMillan DC. The co-ordinated cytokine/hormone response to acute injury incorporates leptin. Cytokine 2000;12:10425.[Medline]
19. Makino S, Asaba K, Nishiyama M, Hashimoto K. Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress. Neuroendocrinology 1999;70:1607.[Medline]
20. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:115561.[Medline]
21. Gross GA, Solenberger T, Philpott T, Holcomb WL Jr, Landt M. Plasma leptin concentrations in newborns of diabetic and nondiabetic mothers. Am J Perinatol 1998;15: 2437.[Medline]
22. Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Honjo H. Leptin directly stimulates aromatase activity in human luteinized granulosa cells. Molec Hum Reprod 1999;5: 70813.
23. Hytinantti TK, Koistinen HA, Teramo K, Karonen SL, Koivisto VA, Andersson S. Increased fetal leptin in type I diabetes mellitus pregnancies complicated by chronic hypoxia. Diabetologia 2000;43:70913.[Medline]
24. Mise H, Sagawa N, Matsumoto T, Yura S, Nanno H, Itoh H, et al. Augmented placental production of leptin in preeclampsia: Possible involvement of placental hypoxia. J Clin Endocrinol Metab 1998;83:32259.
25. Andersen GE, Friis-Hansen B. Neonatal hypertriglyceridemia: A new index of antepartum-intrapartum fetal stress? Acta Paediatr Scand 1976;65:36974.[Medline]
This article has been cited by other articles:
![]() |
D.-M. Alexe, G. Syridou, and E. Th. Petridou Determinants of Early Life Leptin Levels and Later Life Degenerative Outcomes Clin. Med. Res., December 1, 2006; 4(4): 326 - 335. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |